Orbital myiasis on recurrent undifferentiated carcinoma in the COVID-19 era: a case report and brief review of the literature.

COVID-19 Cancer Myiasis Orbital myiasis Undifferentiated carcinoma

Journal

Journal of ophthalmic inflammation and infection
ISSN: 1869-5760
Titre abrégé: J Ophthalmic Inflamm Infect
Pays: Germany
ID NLM: 101553216

Informations de publication

Date de publication:
20 Nov 2021
Historique:
received: 29 03 2021
accepted: 04 10 2021
entrez: 20 11 2021
pubmed: 21 11 2021
medline: 21 11 2021
Statut: epublish

Résumé

Myiasis is defined as the infestation of living tissues by Diptera larvae. Ophthalmic involvement occurs in less than 5% of cases. As the most uncommon type of involvement, orbital myiasis usually affects patients with poor personal hygiene, a low socioeconomic status, a history of surgery, and cancer. In January 2020, an 89-year-old man presented to the Oculoplastic Department of Farabi Eye Hospital (Iran) with a history of left-side progressive orbital mass for six months. A large infiltrative mass of the left orbit with extension to the globe, periorbita, and adnexa was remarkable at the presentation, and its appearance suggested malignancy. Our findings persuaded us to perform exenteration and histopathological evaluation which were reported as "undifferentiated carcinoma". Regular follow-up visits were recommended. In June 2020, with a 3-month delay, the patient presented with the recurrence of the mass complicated with mobile alive larva. Examinations revealed numerous maggots crawling out of an ulcerative and foul-smelling lesion. He stated that fear of COVID-19 infection postponed his follow-up visit. The patient underwent immediate mechanical removal of larvae, followed by wide local excision of the mass. Patients with carcinoma of the adnexal tissues seem to be more prone to myiasis infestation even though it is an uncommon disease. Since COVID-19 is an ongoing pandemic with no end in sight appropriate protocols should be implemented to prevent loss of follow-up in these high risk patients.

Sections du résumé

BACKGROUND BACKGROUND
Myiasis is defined as the infestation of living tissues by Diptera larvae. Ophthalmic involvement occurs in less than 5% of cases. As the most uncommon type of involvement, orbital myiasis usually affects patients with poor personal hygiene, a low socioeconomic status, a history of surgery, and cancer.
FINDINGS RESULTS
In January 2020, an 89-year-old man presented to the Oculoplastic Department of Farabi Eye Hospital (Iran) with a history of left-side progressive orbital mass for six months. A large infiltrative mass of the left orbit with extension to the globe, periorbita, and adnexa was remarkable at the presentation, and its appearance suggested malignancy. Our findings persuaded us to perform exenteration and histopathological evaluation which were reported as "undifferentiated carcinoma". Regular follow-up visits were recommended. In June 2020, with a 3-month delay, the patient presented with the recurrence of the mass complicated with mobile alive larva. Examinations revealed numerous maggots crawling out of an ulcerative and foul-smelling lesion. He stated that fear of COVID-19 infection postponed his follow-up visit. The patient underwent immediate mechanical removal of larvae, followed by wide local excision of the mass.
CONCLUSION CONCLUSIONS
Patients with carcinoma of the adnexal tissues seem to be more prone to myiasis infestation even though it is an uncommon disease. Since COVID-19 is an ongoing pandemic with no end in sight appropriate protocols should be implemented to prevent loss of follow-up in these high risk patients.

Identifiants

pubmed: 34800187
doi: 10.1186/s12348-021-00271-1
pii: 10.1186/s12348-021-00271-1
pmc: PMC8605467
doi:

Types de publication

Journal Article

Langues

eng

Pagination

44

Informations de copyright

© 2021. The Author(s).

Références

Ophthalmology. 1986 Sep;93(9):1228-32
pubmed: 3808634
Int J Oral Maxillofac Surg. 2001 Feb;30(1):83-4
pubmed: 11289628
Indian J Med Microbiol. 2010 Jul-Sep;28(3):257-61
pubmed: 20644320
Am J Ophthalmol. 1973 Mar;75(3):349-64
pubmed: 4697189
Oman J Ophthalmol. 2009 Jan;2(1):41-2
pubmed: 21234224
Case Rep Ophthalmol Med. 2020 Apr 30;2020:5618924
pubmed: 32411489
Indian J Dermatol. 2014 May;59(3):308-9
pubmed: 24891675
Case Rep Ophthalmol Med. 2016;2016:2904346
pubmed: 27595028
Eur J Ophthalmol. 2009 Jul-Aug;19(4):683-5
pubmed: 19551688
Jpn J Ophthalmol. 2003 Jul-Aug;47(4):412-4
pubmed: 12842214
BMJ Case Rep. 2018 Jun 4;2018:
pubmed: 29866693
Orbit. 2012 Apr;31(2):137-9
pubmed: 22489860
BMJ Case Rep. 2016 Aug 05;2016:
pubmed: 27495173
Medicine (Baltimore). 2020 Jan;99(4):e18879
pubmed: 31977893
Acta Ophthalmol Scand. 2004 Oct;82(5):576-84
pubmed: 15453857

Auteurs

Mansooreh Jamshidian-Tehrani (M)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Tehran, 1336616351, Iran.

Kasra Cheraqpour (K)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Tehran, 1336616351, Iran.

Mohammad Amini (M)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Tehran, 1336616351, Iran.

Fahimeh Asadi Amoli (FA)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Tehran, 1336616351, Iran.

Abolfazl Kasaee (A)

Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Qazvin Square, Tehran, 1336616351, Iran. az.kasaee@gmail.com.

Classifications MeSH